REFILE-Petco keeps annual outlook unchanged after muted sales in Q1

Petco Health and Wellness

Petco Health and Wellness

WOOF

0.00

Corrects to remove repeated period from headline


Overview

  • U.S. pet retailer's Q1 revenue slightly beat analyst expectations, rising 0.2% yr/yr

  • Comparable sales returned to positive growth, up 0.7% yr/yr

  • Company reaffirmed full-year 2026 outlook and provided Q2 guidance


Outlook

  • Petco reaffirms FY 2026 net sales outlook of flat to up 1.5% y/y

  • Company expects FY 2026 adjusted EBITDA of $415 mln to $430 mln

  • Petco sees Q2 2026 net sales up about 0.3% y/y, adjusted EBITDA $110 mln to $112 mln


Result Drivers

  • CONSUMABLES IMPROVEMENT - Co said improvement in consumables business contributed to Q1 results

  • SERVICES OUTPERFORMANCE - Services business continued to outperform and was described as a key growth engine

  • OPERATIONAL IMPROVEMENTS - Co said operational and economic improvements are materializing, supporting positive comp sales


Company press release: ID:nPnTRPNxa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Slight Beat*

$1.50 bln

$1.49 bln (9 Analysts)

Q1 Comparable sales GROWTH

0.7%

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 8 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy."

  • Wall Street's median 12-month price target for Petco Health and Wellness Company Inc is $3.75, about 26.7% above its June 2 closing price of $2.96

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 14 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.